Unlocking the Anti-Obesity Potential of the Genus Scutellaria: Pharmacological Insights and Therapeutic Perspectives

Obesity represents a growing global health challenge, driving the need for safer and more effective therapeutic strategies. Natural products, particularly medicinal plants, have gained increasing attention as potential sources of anti-obesity agents due to their diverse bioactive compounds and multi-target mechanisms. The genus Scutellaria (Lamiaceae) is rich in phytochemicals, especially flavonoids such as baicalin, baicalein, and wogonin, which have been reported to modulate key metabolic pathways involved in obesity. This review aims to comprehensively summarize current evidence on selected Scutellaria species with potential anti-obesity activity, focusing on their phytochemical profiles and pharmacological mechanisms. A literature search was conducted using PubMed, Scopus, and Google Scholar databases, and relevant studies were selected based on predefined inclusion criteria. The findings indicate that Scutellaria-derived compounds may exert anti-obesity effects through multiple mechanisms, including inhibition of adipogenesis, regulation of lipid metabolism, improvement of energy homeostasis, and suppression of obesity-associated inflammation. Preclinical studies provide substantial evidence supporting these biological activities; however, clinical validation remains limited. In conclusion, Scutellaria species represent promising candidates for the development of novel anti-obesity therapies. Further studies, particularly well-designed clinical trials, are necessary to confirm their efficacy, safety, and therapeutic applicability in humans.